C12N 2770/32422
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2770/32422 (New viral proteins or individual genes, new structural or functional aspects of) appears on 39 US grants and 16 published applications in this corpus.
Search patents in C12N- Granted patents
- 39
- Published applications
- 16
- Assignees
- 24
- Inventors
- 91
- Latest grant
- 2 Aug 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 3 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 4 | 0 |
| 1999 | 0 | 0 |
| 2000 | 9 | 0 |
| 2001 | 2 | 0 |
| 2002 | 3 | 1 |
| 2003 | 1 | 6 |
| 2004 | 2 | 1 |
| 2005 | 2 | 2 |
| 2006 | 0 | 1 |
| 2007 | 1 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 1 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 1 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Protein M fusion proteins and uses2 Aug 2022US 11,401,309 B2
- Process for the preparation and purification of recombinant proteins17 Feb 2015US 8,956,812 B2Bharat Biotech International Limited
- Method for preparing recombinant antigen complex using rotavirus nanoparticle24 Jun 2014US 8,758,762 B2Chung-Ang University Industry-Academy Cooperation Foundation
- Synthetic peptides immunoreactive with hepatitis A virus antibodies29 May 2007US 7,223,535 B2Centers for Disease Control
- Hepatitis A virus nucleotide sequences, recombinant proteins and uses thereof13 Sep 2005US 6,942,965 B2Chiron Corporation
- Protein m fusion proteins and uses24 Mar 2022US 2022/0089656 A1
- Virus-like particle vaccines30 Jun 2016US 2016/0185826 A1Medigen Biotechnology Corporation
- Method for Preparing Recombinant Antigen Complex Using Rotavirus Nanoparticle22 Dec 2011US 2011/0311573 A1Chung-Ang University Industry-Academy Cooperation Foundation
- Immunotherapy and prevention of autoimmune hepatitis9 Dec 2010US 2010/0310656 A1Immunitor USA Inc.
- Process for the preparation and purification of recombinant proteins5 Jul 2007US 2007/0154880 A1Bharat Biotech International Limited
Most cited
By later US patents
- Recombianant Hepatitis a virus59US 5,294,548 AAmerican Biogenetic Sciences, Inc. · 1994
- Hepatitis A--subunit antigen15US 4,614,793 AMerck & Co., Inc. · 1986
- Attenuated hepatitis a virus vaccine which grows in MRC-5 cells14US 6,180,110 B2The United States of America as represented by the Department of Health and Human Services · 2001
- Methods of detecting hepatitis A virus11US 5,516,630 AThe United States of America as represented by the Department of Health and Human Services · 1996
- Hepatitis A virus deletion mutants and vaccine formulations containing the same11US 5,766,906 AThe University of North Carolina at Chapel Hill · 1998